Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 95

1.

Erratum: Author correction.

Lee YJ, Kim YM, Kim HJ, Choi SW, Lee SW, Park JY, Kim DY, Suh DS, Kim JH, Kim YT, Nam JH.

Obstet Gynecol Sci. 2017 Nov;60(6):621. doi: 10.5468/ogs.2017.60.6.621. Epub 2017 Oct 31.

2.

Safety of fertility-sparing surgery for stage I ovarian clear cell carcinoma.

Park JY.

J Gynecol Oncol. 2017 Nov;28(6):e91. doi: 10.3802/jgo.2017.28.e91. No abstract available.

3.
4.

Significance of Ovarian Endometriosis on the Prognosis of Ovarian Clear Cell Carcinoma.

Park JY, Kim DY, Suh DS, Kim JH, Kim YM, Kim YT, Nam JH.

Int J Gynecol Cancer. 2017 Sep 19. doi: 10.1097/IGC.0000000000001136. [Epub ahead of print]

PMID:
28930811
5.

Port-site recurrence 6 years after laparoscopic surgery for early stage ovarian borderline malignancy.

Shin YJ, Lee HJ, Kim KR, Nam JH, Park JY.

J Obstet Gynaecol. 2017 Aug 23:1-2. doi: 10.1080/01443615.2017.1340437. [Epub ahead of print] No abstract available.

PMID:
28830247
6.

Effects of the Crack Tip Constraint on the Fracture Assessment of an Al 5083-O Weldment for Low Temperature Applications.

Moon DH, Park JY, Kim MH.

Materials (Basel). 2017 Jul 18;10(7). pii: E815. doi: 10.3390/ma10070815.

7.

The Value of Preoperative Positron Emission Tomography/Computed Tomography in Node-Negative Endometrial Cancer on Magnetic Resonance Imaging.

Park JY, Lee JJ, Choi HJ, Song IH, Sung CO, Kim HO, Chae SY, Kim YT, Nam JH.

Ann Surg Oncol. 2017 Aug;24(8):2303-2310. doi: 10.1245/s10434-017-5901-8. Epub 2017 May 26.

PMID:
28550488
8.

Prognostic value of metabolic parameters determined by preoperative ¹⁸F-FDG PET/CT in patients with uterine carcinosarcoma.

Lee HJ, Lee JJ, Park JY, Kim JH, Kim YM, Kim YT, Nam JH.

J Gynecol Oncol. 2017 Jul;28(4):e43. doi: 10.3802/jgo.2017.28.e43.

9.

Stratification of risk groups according to survival after recurrence in endometrial cancer patients.

Shim SH, Kim DY, Kim HJ, Lee SW, Park JY, Suh DS, Kim JH, Kim YM, Kim YT, Nam JH.

Medicine (Baltimore). 2017 May;96(21):e6920. doi: 10.1097/MD.0000000000006920.

10.

Role of robotic surgery in cervical malignancy.

Park JY, Nam JH.

Best Pract Res Clin Obstet Gynaecol. 2017 Nov;45:60-73. doi: 10.1016/j.bpobgyn.2017.03.009. Epub 2017 Apr 24. Review.

PMID:
28533153
11.

Significance of body weight change during fertility-sparing progestin therapy in young women with early endometrial cancer.

Park JY, Seong SJ, Kim TJ, Kim JW, Bae DS, Nam JH.

Gynecol Oncol. 2017 Jul;146(1):39-43. doi: 10.1016/j.ygyno.2017.05.002. Epub 2017 May 16.

PMID:
28526167
12.

Prognostic significance of preoperative ¹⁸F-FDG PET/CT in uterine leiomyosarcoma.

Park JY, Lee JW, Lee HJ, Lee JJ, Moon SH, Kang SY, Cheon GJ, Chung HH.

J Gynecol Oncol. 2017 May;28(3):e28. doi: 10.3802/jgo.2017.28.e28. Epub 2017 Feb 2.

13.

Practice guidelines for management of cervical cancer in Korea: a Korean Society of Gynecologic Oncology Consensus Statement.

Lim MC, Lee M, Shim SH, Nam EJ, Lee JY, Kim HJ, Lee YY, Lee KB, Park JY, Kim YH, Ki KD, Song YJ, Chung HH, Kim S, Lee JW, Kim JW, Bae DS, Lee JM.

J Gynecol Oncol. 2017 May;28(3):e22. doi: 10.3802/jgo.2017.28.e22. Epub 2017 Mar 15.

14.

Analysis of outcomes and prognostic factors after fertility-sparing surgery in malignant ovarian germ cell tumors.

Park JY, Kim DY, Suh DS, Kim JH, Kim YM, Kim YT, Nam JH.

Gynecol Oncol. 2017 Jun;145(3):513-518. doi: 10.1016/j.ygyno.2017.03.023. Epub 2017 Mar 31.

PMID:
28372870
15.

Preoperative Predictive Factors for Complete Cytoreduction and Survival Outcome in Epithelial Ovarian, Tubal, and Peritoneal Cancer After Neoadjuvant Chemotherapy.

Baek MH, Lee SW, Park JY, Rhim CC, Kim DY, Suh DS, Kim JH, Kim YM, Kim YT, Nam JH.

Int J Gynecol Cancer. 2017 Mar;27(3):420-429. doi: 10.1097/IGC.0000000000000924.

PMID:
28187098
16.

Investigation of New Therapeutic Targets in Undifferentiated Endometrial Sarcoma.

Baek MH, Park JY, Rhim CC, Kim JH, Park Y, Kim KR, Nam JH.

Gynecol Obstet Invest. 2017;82(4):329-339. doi: 10.1159/000454769. Epub 2017 Jan 27.

PMID:
28125812
17.

A postoperative scoring system for distant recurrence in node-positive cervical cancer patients after radical hysterectomy and pelvic lymph node dissection with para-aortic lymph node sampling or dissection.

Lee YJ, Kim DY, Lee SW, Park JY, Suh DS, Kim JH, Kim YM, Kim YT, Nam JH.

Gynecol Oncol. 2017 Mar;144(3):536-540. doi: 10.1016/j.ygyno.2017.01.001. Epub 2017 Jan 17.

PMID:
28108027
18.

Estimation of utility weights for human papilloma virus-related health states according to disease severity.

Ock M, Park JY, Son WS, Lee HJ, Kim SH, Jo MW.

Health Qual Life Outcomes. 2016 Nov 28;14(1):163.

19.

Hysteroscopy in fertility-sparing management for early endometrial cancer: a double-edged sword.

Park JY.

J Gynecol Oncol. 2017 Jan;28(1):e16. doi: 10.3802/jgo.2017.28.e16. Epub 2016 Nov 17. No abstract available.

20.

Prediction model for para-aortic lymph node metastasis in patients with locally advanced cervical cancer.

Shim SH, Kim DY, Lee SJ, Kim SN, Kang SB, Lee SW, Park JY, Suh DS, Kim JH, Kim YM, Kim YT, Nam JH.

Gynecol Oncol. 2017 Jan;144(1):40-45. doi: 10.1016/j.ygyno.2016.11.011. Epub 2016 Nov 14.

PMID:
27855989

Supplemental Content

Loading ...
Support Center